Vicky Baillie

Vicky Baillie

University of the Witwatersrand - Johannesburg / South Africa
Others
AD Scientific Index ID: 4989238
Universiteit van die Witwatersrand
person_outline Vicky Baillie's MOST POPULAR ARTICLES
1-) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
2-) Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review … - T Shi, DA McAllister, KL O\\\'Brien, EAF Simoes, SA Madhi, BD Gessner, ...
3-) Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant - SA Madhi, V Baillie, CL Cutland, M Voysey, AL Koen, L Fairlie, ...
4-) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...The Lancet 397 (10277), 881-891, 202113952021
5-) SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responsesW Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ...Cell 185 (3), 467-484. e15, 20229852022